ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
70,212.00
0.12%
S&P 500
5,320.64
-0.01%
Dow Jones
39,828.84
-0.11%
US Dollar vs Yen
156.5365
0.18%
Brent Oil
82.335
-0.13%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. AQSE
  6. Apollon Formularies plc (APOL)

  7. Apollon Formularies plc (APOL) ニュース

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AQSE:APOL
日付受信時刻ニュースソース見出しコード企業名
2024/05/0320 : 59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
2024/05/0123 : 00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
2024/02/2019 : 59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
2024/01/0217 : 18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
2023/12/0520 : 59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
2023/11/2120 : 51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
2023/09/2915 : 00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
2023/09/1917 : 18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
2023/08/0318 : 51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
2023/08/0220 : 19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
2023/07/2419 : 00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
2023/07/0101 : 32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
2023/05/1101 : 05UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
2023/04/1122 : 00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
2023/03/2121 : 00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
2023/03/1516 : 00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
2023/01/1216 : 00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
2022/12/3021 : 37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
2022/12/0216 : 00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
2022/09/3017 : 50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
2022/09/1315 : 02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
2022/08/0217 : 11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
2022/07/2615 : 00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
2022/07/0100 : 29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
2022/06/3020 : 33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
2022/06/1721 : 23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
2022/05/0520 : 07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
2022/03/0216 : 01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
2022/02/0916 : 00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
2022/02/0315 : 59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
 Showing the most relevant articles for your search:AQSE:APOL

最近閲覧した銘柄

USOTC
ADDYY
Adidas (QX)
COIN
SOLUSD
Solana
USOTC
BNPQY
BNP Paribas (QX)
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
NYSE
AXP
American Express
CCOM
US100
US Tech 100
COIN
ETHUSD
Ethereum
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有